Pravastatin and placental insufficiency associated disorders: A systematic review and meta-analysis
Conclusion: Pravastatin treatment prolonged pregnancy duration and improved associated obstetrical outcomes in pregnancies complicated with uteroplacental insufficiency disorders in cohort studies.Systematic Review Registration:https://www.crd.york.ac.uk/prospero/ identifier CRD42020165804 17/2/2020.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Antiphospholipid Syndrome | Cardiology | Cardiovascular | Cholesterol | Databases & Libraries | Drugs & Pharmacology | Heart | Hughes Syndrome | Intensive Care | OBGYN | Perinatology & Neonatology | Pravastatin | Pregnancy | Statin Therapy | Statistics | Study | Women